Neurologic complications in immune-mediated heparin-induced thrombocytopenia

Neurology

Volumn 54, Issue 6, 2000, Pages 1240-1245

  Pohl, C ^a   Harbrecht, U ^a   Greinacher, A ^b   Theuerkauf, I ^a   Biniek, R ^c   Hanfland, P ^a   Klockgether, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Rheinische Landesklinik Bonn   (Germany)

Author keywords

Cerebral venous thrombosis; HIT; Stroke; Transient confusional state

Indexed keywords

DANAPAROID; HEPARIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONFUSION; FEMALE; HEPARINIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; NEUROLOGICAL COMPLICATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; STROKE; THROMBOCYTOPENIA;

EID: 0034724145     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.6.1240     Document Type: Article

References (40)

1. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79:1-7.
2. Chong BH, Fawaz I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989;73:235-240.
3. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68:95-96. Letter.
4. Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988;72:925-930.
5. Carlsson LE, Santoso S, Baurichter G, et al. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood 1998;92:1526-1531.
6. Arepally G, McKenzie SE, Jiang XM, Poncz M, Cines DB. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 1997;89:370-375.
7. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-507.
8. Benhamou AC, Gruel Y, Barsotti J, et al. The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT, 26 cases). Int Angiol 1985;4:303-310.
9. Boon DM, Michiels JJ, Tanghe HL, Kappers KM. Heparin-induced thrombocytopenia with multiple cerebral infarctions simulating thrombotic thrombocytopenic purpura. A case report. Angiology 1996;47:407-411.
10. Makhoul RG, Greenberg CS, McCann RL. Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vase Surg 1986;4:522-528.
11. Ramirez-Lassepas M, Cipolle RJ, Rodvold KA, et al. Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease. Neurology 1984;34:736-740.
12. Chang JC. White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases. Heart Lung 1987;16:403-407.
13. Maurin N, Biniek R, Heintz B, Kierdorf H. Heparin-induced thrombocytopenia and thrombosis with spinal ischaemia-recovery of platelet count following a change to a low molecular weight heparin. Intensive Care Med 1991;17:185-186. Letter.
14. Calhoun BC, Hesser JW. Heparin-associated antibody with pregnancy: discussion of two cases. Am J Obstet Gynecol 1987;156:964-966.
15. Walther EU, Tiecks FP, Haberl RL. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia. Neurology 1996;47: 300-301.
16. Meytes D, Ayalon H, Virag I, Weisbort Y, Zakut H. Heparin-induced thrombocytopenia and recurrent thrombosis in pregnancy. A case report. J Reprod Med 1986;31:993-996.
17. Kyritsis AP, Williams EC, Schutta HS. Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 1990;21:1503-1505.
18. Meyer Lindenberg A, Quenzel EM, Bierhoff E, Wolff H, Schindler E, Biniek R. Fatal cerebral venous sinus thrombosis in heparin-induced thrombotic thrombocytopenia. Eur Neurol 1997;37:191-192.
19. Van-der Weyden MB, Hunt H, McGrath K, et al. Delayed-onset heparin-induced thrombocytopenia. A potentially malignant syndrome. Med J Aust 1983;2:132-135.
20. Warkentin TE, Hirte HW, Anderson DR, Wilson WE, O'Connell GJ, Lo RC. Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med 1994;97:489-491.
21. Greinacher A, Michels I, Kiefel V, Mueller EC. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991;66:734-736.
22. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-1335.
23. Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross FS. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 1997;56:12-16.
24. Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 1975;45:395-401.
25. Eichler P, Budde U, Haas S, et al. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost 1999;81:625-629.
26. Pohl C, Klockgether T, Greinacher A, Hanfland P, Harbrecht U. Neurological complications in heparin-induced thrombocytopenia [research letter]. Lancet 1999;353:1678-1679.
27. Kappers KM, Boon DM, Hop WC, et al. Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases. Br J Haematol 1997;96:442-446.
28. Godal HC. Report of the International Committee on Thrombosis and Haemostasis. Thrombocytopenia and heparin. Thromb Haemost 1980;43:222-224.
29. Boshkov LK, Warkentin TE, Hayward CP, Andrew M, Kelton JG. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 1993;84:322-328.
30. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-88.
31. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987;316:581-589.
32. Greinacher A, Poetzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994;71:247-251.
33. Olbrich K, Wiersbitzky M, Wacke W, et al. Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin). Blood Coagul Fibrinolysis 1998;9:273-277.
34. Lee DH, Warkentin TE, Denomme GA, Lagrotteria DD, Kelton JG. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Thromb Haemost 1998; 79:50-53.
35. Gallus A, Cade J, Ockelford P, et al. Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group. Thromb Haemost 1993;70:562-567.
36. Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 1993;70:554-561.
37. Tardy-Poncet B, Tardy B, Reynaud J, et al. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia. Chest 1999; 115:1616-1620.
38. Vun CM, Evans S, Chong BH. Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia. Thromb Res 1996;81:525-532.
39. Greinacher A, Volpel H, Janssens U, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999;99:73-80.
40. Greinacher A, Janssens U, Berg G, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999;100: 587-593.